Evidence map›Paper›PMID 39130596›Full record

ReviewACS omega2024

Influence of Physicochemical Properties of Iron Oxide Nanoparticles on Their Antibacterial Activity.

Kishan Nandi Shoudho, Shihab Uddin, Md Mahamudul Hasan Rumon, Md Salman Shakil

Abstract readReview
In one paragraph

Review in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Eco-friendly synthesis of FeFrontiers in microbiology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Therapeutic potential of iron oxide nanoparticles for cutaneous leishmaniasis: a systematic review ofThe journal of venomous animals and toxins including tropical diseases · 2025
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kishan Nandi ShoudhoDepartment of Mathematics and Natural Sciences, Brac University, Kha-224 Merul Badda, Dhaka 1212, Bangladesh.ORCID https://orcid.org/0009-0000-3962-7255
Shihab UddinDepartment of Bioengineering, King Fahd University of Petroleum & Minerals, Dhahran 31261, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0001-5464-570X
Md Mahamudul Hasan RumonDepartment of Mathematics and Natural Sciences, Brac University, Kha-224 Merul Badda, Dhaka 1212, Bangladesh.ORCID https://orcid.org/0000-0002-0459-5035
Md Salman ShakilDepartment of Mathematics and Natural Sciences, Brac University, Kha-224 Merul Badda, Dhaka 1212, Bangladesh.ORCID https://orcid.org/0000-0002-8922-9500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing occurrence of infectious diseases caused by antimicrobial resistance organisms urged the necessity to develop more potent, selective, and safe antimicrobial agents. The unique magnetic and tunable properties of iron oxide nanoparticles (IONPs) make them a promising candidate for different theragnostic applications, including antimicrobial agents. Though IONPs act as a nonspecific antimicrobial agent, their antimicrobial activities are directly or indirectly linked with their synthesis methods, synthesizing precursors, size, shapes, concentration, and surface modifications. Alteration of these parameters could accelerate or decelerate the production of reactive oxygen species (ROS). An increase in ROS role production disrupts bacterial cell walls, cell membranes, alters major biomolecules (e.g., lipids, proteins, nucleic acids), and affects metabolic processes (e.g., Krebs cycle, fatty acid synthesis, ATP synthesis, glycolysis, and mitophagy). In this review, we will investigate the antibacterial activity of bare and surface-modified IONPs and the influence of physiochemical parameters on their antibacterial activity. Additionally, we will report the potential mechanism of IONPs' action in driving this antimicrobial activity.

Identifiers

PMID39130596
PMCPMC11308002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.